Status:

RECRUITING

Sinus Disease in Young Children With Cystic Fibrosis

Lead Sponsor:

University of California, Los Angeles

Collaborating Sponsors:

University of Kansas Medical Center

Children's Hospital Medical Center, Cincinnati

Conditions:

Cystic Fibrosis in Children

Cystic Fibrosis

Eligibility:

All Genders

2-8 years

Brief Summary

This is a prospective, observational study examining the impact of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators on chronic rhinosinusitis (CRS) and olfactory ...

Detailed Description

This multi-center, prospective, observational study investigates the effects of highly effective modulator therapy (HEMT) on chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) in young childr...

Eligibility Criteria

Inclusion

  • HEMT Group:
  • Children with documentation of a CF diagnosis
  • Age 2-8 years old at first study visit
  • CFTR mutation consistent with FDA labeled indication of highly effective modulator therapy (ivacaftor or elexacaftor/tezacaftor/ivacaftor)
  • Clinician intent to prescribe ivacaftor or ETI so that enrollment is before start of HEMT
  • Non-HEMT/Control Group:
  • Children with documentation of a CF diagnosis
  • Age 2-8 years at first study visit
  • Ineligible for highly effective modulator therapy (ivacaftor or elexacaftor/tezacaftor/ivacaftor) based on CFTR mutation or clinical decision not to initiate HEMT if eligible

Exclusion

  • For Both Groups:
  • Use of an investigational drug within 28 days prior to the first study visit
  • Use of ivacaftor or elexacaftor/tezacaftor/ivacaftor within the 180 days prior to and including the first study visit
  • Use of chronic oral corticosteroids within the 28 days prior to and including the first study visit.
  • Sinus surgery within 180 days prior to the first study visit

Key Trial Info

Start Date :

April 12 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2026

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06191640

Start Date

April 12 2023

End Date

April 1 2026

Last Update

September 30 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

2

University of Iowa

Iowa City, Iowa, United States, 52242

3

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

4

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229-3039